Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Prudenta: Electronic Solution for Safer Drugs

Project description

AI-supported software for drug safety monitoring

The search for possible adverse reactions to a drug, or safety signal detection, is mandatory for all pharmaceutical companies and has to be performed in all countries where the drug is available. Until recently, this process was done manually. The EU-funded prudenta project aims to develop an innovative software solution for drug safety prediction, which will allow for the automation of signal detection for adverse reactions. As part of the project work, a cloud-based software solution based on artificial intelligence will be developed. Moreover, the software will be tested and the functionality of modules will be expanded and improved in the process of preparation for commercialisation.

Objective

Prudenta is an innovative, artificial intelligence-supported cloud-based solution that will enable pharmaceutical companies to automate local medical literature monitoring for drug safety signals (possible adverse reactions) and thus drastically improve the safety of drugs, as well as reduce the costs of drugs in the market. Safety signal searching is mandatory by law to all pharmaceutical companies and must be performed in each country, where the drug is traded. Until now - such searching was manual, in many instances not even electronic.


If successful, Prudenta would have a three-fold impact: 1) Safer drugs due to automation of the process and exclusion of the human error; 2) Cheaper drugs due to reduction of costs of inefficient use of experienced and educated personnel in pharmaceutical companies for manual searching; 3) Increase in employment in EU for support of all Prudenta activities (software development, operations, sales & marketing, etc.).

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

SIA REPHINE BALTICUM
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
DZIRNAVU IELA 34A - 2
1010 RIGA
Latvia

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Latvija Latvija Rīga
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0